Profile

Dr. Andrew Kolodny is the Medical Director for the Opioid Policy Research Collaborative. He also serves as President of Physicians for Responsible Opioid Prescribing, an organization that advocates for more cautious opioid prescribing. He is one of the nation's leading experts on the opioid crisis. Dr. Kolodny has assisted Committees of the United States Senate and House of Representatives, the U.S. Department of Justice and state Attorneys General in their investigations of the opioid industry and pain organizations. He is currently serving as an expert witness in litigation by state governments against the opioid industry.

Dr. Kolodny previously served as Chief Medical Officer for Phoenix House, a national
nonprofit addiction treatment agency and Chair of Psychiatry at Maimonides Medical
Center in New York City. Dr. Kolodny has a long-standing interest in public health. He
began his career working for the New York City Department of Health and Mental
Hygiene in the Office of the Executive Deputy Commissioner. For New York City, he
helped develop and implement multiple programs to improve the health of New Yorkers
and save lives, including citywide buprenorphine programs, naloxone overdose
prevention programs and emergency room-based screening, brief intervention and
referral to treatment (SBIRT) programs for drug and alcohol misuse.

Dr. Kolodny's testimony before for the United States Congress is available here.

Senate Caucus on International Narcotics Control. May 14, 2014
America's Addiction to Opioids: Heroin and Prescription Drug Use

Homeland Security and Governmental Affairs. January 17, 2018
Unintended Consequences: Medicaid and the Opioid Epidemic

Committee on Energy & Commerce, Subcommittee on Health, U.S. House of Representatives. February 28, 2018
Combatting the Opioid Crisis

See the listing of Dr. Kolodny's publications on PubMed
here.